MarketCap
Facebook
X
TelegramQuarterly report 2025-Q4
added 02-11-2026
Organovo Holdings Depreciation & Amortization 2011-2026 | ONVO
Annual Depreciation & Amortization Organovo Holdings
| 2025 | 2024 | 2023 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 266 K | 280 K | 293 K | 41 K | 1.14 M | 980 K | 1.27 M | 1.15 M | 815 K | 472 K | 387 K | - | 195 K | 68 K |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 1.27 M | 41 K | 566 K |
Quarterly Depreciation & Amortization Organovo Holdings
| 2025-Q4 | 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | 61 K | - | - | - | 70 K | - | - | - | 67 K | - | - | 234 K | 50 K | - | - | 96 K | 59 K | - | - | 18 K | 8 K | 4 K | - | 1.14 M | 379 K | 205 K | - | 824 K | 570 K | - | - | - | 326 K | - | - | 824 K | 502 K | - | - | 560 K | 324 K | - | - | 334 K | 208 K | - | - | 288 K | 190 K | 80 K | - | 178 K | 100 K | 17 K | - | 49.9 K | 32.4 K | 15.6 K |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 1.14 M | 4 K | 252 K |
Depreciation & Amortization of other stocks in the Diagnostics research industry
| Issuer | Depreciation & Amortization | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Akumin
AKU
|
98.2 M | - | -17.87 % | $ 25.9 M |  Canada |
 |
Aspira Women's Health
AWH
|
264 K | - | -6.19 % | $ 10.5 M |  USA |
 |
Accelerate Diagnostics
AXDX
|
1.7 M | - | -61.36 % | $ 2.46 M | USA |
 |
Burning Rock Biotech Limited
BNR
|
47.8 M | $ 29.14 | -3.75 % | $ 326 M |  China |
 |
Biocept
BIOC
|
1.66 M | - | -13.05 % | $ 7.29 M | USA |
 |
BioNano Genomics
BNGO
|
14 M | $ 1.1 | 0.46 % | $ 1.4 M | USA |
 |
Check-Cap Ltd.
CHEK
|
161 K | - | - | $ 9.42 M |  Israel |
 |
Co-Diagnostics
CODX
|
1.23 M | - | - | $ 79.8 M | USA |
 |
DarioHealth Corp.
DRIO
|
473 K | $ 11.38 | 1.16 % | $ 323 M | Israel |
 |
DexCom
DXCM
|
252 M | $ 70.29 | 8.0 % | $ 27.4 B | USA |
 |
Celcuity
CELC
|
130 K | $ 103.65 | -1.16 % | $ 4.09 B | USA |
 |
Chembio Diagnostics
CEMI
|
2.55 M | - | 0.22 % | $ 16.8 M | USA |
 |
Castle Biosciences
CSTL
|
16 M | $ 32.89 | 3.09 % | $ 914 M | USA |
 |
Danaher Corporation
DHR
|
721 M | $ 211.14 | -1.74 % | $ 154 B | USA |
 |
Quest Diagnostics Incorporated
DGX
|
493 M | $ 205.13 | -0.82 % | $ 22.8 B | USA |
 |
Global Cord Blood Corporation
CO
|
43.3 M | - | - | $ 399 M | China |
 |
Fulgent Genetics
FLGT
|
24.9 M | $ 23.24 | 1.18 % | $ 703 M | USA |
 |
Enzo Biochem
ENZ
|
1.27 M | - | -8.98 % | $ 14.8 K | USA |
 |
CareDx, Inc
CDNA
|
14.4 M | $ 19.6 | 2.62 % | $ 1.05 B | USA |
 |
DermTech
DMTK
|
200 K | - | -11.32 % | $ 2.94 M | USA |
 |
Interpace Biosciences
IDXG
|
300 K | $ 1.85 | - | $ 8.12 M | USA |
 |
Exact Sciences Corporation
EXAS
|
120 M | $ 103.32 | 0.09 % | $ 19.1 B | USA |
 |
Heska Corporation
HSKA
|
14 M | - | - | $ 1.31 B | USA |
 |
Lantheus Holdings
LNTH
|
64.6 M | $ 68.71 | -0.02 % | $ 4.75 B | USA |
 |
Guardant Health
GH
|
42.4 M | $ 104.76 | 1.95 % | $ 12.9 B | USA |
 |
QIAGEN N.V.
QGEN
|
203 M | - | - | $ 10.6 B |  Niderland |
 |
National Research Corporation
NRC
|
140 K | $ 12.09 | -5.81 % | $ 297 M | USA |
 |
HTG Molecular Diagnostics
HTGM
|
587 K | - | -20.0 % | $ 1.06 M | USA |
 |
Charles River Laboratories International
CRL
|
362 M | $ 160.2 | 0.91 % | $ 8.23 B | USA |
 |
IDEXX Laboratories
IDXX
|
130 M | $ 627.58 | 1.68 % | $ 51.8 B | USA |
 |
Illumina
ILMN
|
354 M | $ 115.9 | 1.27 % | $ 18.4 B | USA |
 |
OPKO Health
OPK
|
98.2 M | $ 1.24 | 2.48 % | $ 861 M | USA |
 |
IQVIA Holdings
IQV
|
1.11 B | $ 166.72 | -1.27 % | $ 30.2 B | USA |
 |
Natera
NTRA
|
16.7 M | $ 204.66 | -1.53 % | $ 20.1 B | USA |
|
Biodesix
BDSX
|
5.77 M | $ 11.55 | 6.6 % | $ 1.5 B | USA |
 |
Personalis
PSNL
|
10.9 M | $ 8.22 | -2.09 % | $ 487 M | USA |
 |
Laboratory Corporation of America Holdings
LH
|
644 M | $ 281.39 | 1.13 % | $ 23.6 B | USA |
 |
ICON Public Limited Company
ICLR
|
488 M | $ 95.34 | 19.06 % | $ 7.86 B |  Irlanda |
 |
Biomerica
BMRA
|
87 K | $ 2.25 | 4.19 % | $ 5.17 M | USA |
 |
Bioventus
BVS
|
57.4 M | $ 8.22 | 1.48 % | $ 515 M | USA |
 |
Medpace Holdings
MEDP
|
27.2 M | $ 429.09 | 3.14 % | $ 12.4 B | USA |